Tenax Therapeutics (TENX) Retained Earnings: 2011-2017
Historic Retained Earnings for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to -$212.2 million.
- Tenax Therapeutics' Retained Earnings fell 21.22% to -$212.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$212.2 million, marking a year-over-year decrease of 21.22%. This contributed to the annual value of -$204.7 million for FY2016, which is N/A change from last year.
- As of Q3 2017, Tenax Therapeutics' Retained Earnings stood at -$212.2 million, which was down 0.59% from -$210.9 million recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Retained Earnings ranged from a high of -$115.2 million in Q1 2013 and a low of -$212.2 million during Q3 2017.
- Over the past 3 years, Tenax Therapeutics' median Retained Earnings value was -$204.7 million (recorded in 2016), while the average stood at -$191.7 million.
- Data for Tenax Therapeutics' Retained Earnings shows a maximum YoY declined of 27.33% (in 2016) over the last 5 years.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Retained Earnings stood at -$117.0 million in 2013, then reached -$160.7 million in 2015, then declined by 27.33% to -$204.7 million in 2016, then fell by 21.22% to -$212.2 million in 2017.
- Its last three reported values are -$212.2 million in Q3 2017, -$210.9 million for Q2 2017, and -$207.9 million during Q1 2017.